Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$210,916
New position
Shares Held
777
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#658
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 2%
Shared 0%
None 98%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $3,773,855 across 7 Diagnostics & Research names. NTRA ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,112 | $1,058,872 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,414 | $744,386 | |
| 3 | DGX |
Quest Diagnostics Inc
|
3,199 | $678,028 | |
| 4 | DHR |
Danaher Corp /De/
|
3,141 | $598,297 | |
| 5 | ILMN |
Illumina, Inc.
|
2,749 | $483,356 | |
| 6 | NTRA |
Natera, Inc.
This page
|
777 | $210,916 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
2,842 | $0 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,916 | 777 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||